| Group I (≤12 months) | Group II (13 months - 23 month) | Group III (≥24 month) | Chi square test/ ANOVA test** | |||||
X2/f** | P value | ||||||||
Sex | Female | 13 | 37.1% | 16 | 47.1% | 15 | 41.7% | 0.698 | 0.705 |
Male | 22 | 62.9% | 18 | 52.9% | 21 | 58.3% | |||
Cons | Negative | 24 | 68.6% | 21 | 61.8% | 21 | 58.3% | 0.822 | 0.663 |
Positive | 11 | 31.4% | 13 | 38.2% | 15 | 41.7% | |||
Age (months) | Mean ± SD | 9.63 ± 1.97 | 17.18 ± 2.93 | 31.42 ± 6.47 | 235.945** | <0.001** |